{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:34:58Z","timestamp":1790494498470,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1455-1","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T15:47:31Z","timestamp":1509637651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis"],"prefix":"10.1186","volume":"19","author":[{"given":"Marije K.","family":"Verheul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel P. M.","family":"Vierboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert A.","family":"\u2019t Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene E. M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"issue":"7","key":"1455_CR1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-152-7-201004060-00010","volume":"152","author":"PF Whiting","year":"2010","unstructured":"Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M, Beynon R, Ben-Shlomo Y, Axford J, Dieppe P. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med. 2010;152(7):456\u201364. w155-466.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1455_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nri.2016.124","volume":"17","author":"V Malmstrom","year":"2017","unstructured":"Malmstrom V, Catrina AI, Klareskog L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2017;17(1):60\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1455_CR3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1455_CR4","doi-asserted-by":"crossref","unstructured":"Trouw LA, Rispens T, Toes RE. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(6):331\u201339.","DOI":"10.1038\/nrrheum.2017.15"},{"issue":"42","key":"1455_CR5","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA. 2011;108(42):17372\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1455_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-015-0536-2","volume":"17","author":"M Brink","year":"2015","unstructured":"Brink M, Verheul MK, Ronnelid J, Berglin E, Holmdahl R, Toes RE, Klareskog L, Trouw LA, Rantapaa-Dahlqvist S. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis Res Ther. 2015;17:25.","journal-title":"Arthritis Res Ther."},{"issue":"8","key":"1455_CR7","doi-asserted-by":"crossref","first-page":"e0161141","DOI":"10.1371\/journal.pone.0161141","volume":"11","author":"A Montes","year":"2016","unstructured":"Montes A, Regueiro C, Perez-Pampin E, Boveda MD, Gomez-Reino JJ, Gonzalez A. Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies. PLoS One. 2016;11(8):e0161141.","journal-title":"PLoS One"},{"issue":"1","key":"1455_CR8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-016-1173-0","volume":"18","author":"A Pecani","year":"2016","unstructured":"Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Di Franco M, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, et al. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Arthritis Res Ther. 2016;18(1):276.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1455_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3899\/jrheum.150179","volume":"43","author":"GJ Challener","year":"2016","unstructured":"Challener GJ, Jones JD, Pelzek AJ, Hamilton BJ, Boire G, de Brum-Fernandes AJ, Masetto A, Carrier N, Menard HA, Silverman GJ, et al. Anti-carbamylated protein antibody levels correlate with anti-Sa (citrullinated vimentin) antibody levels in rheumatoid arthritis. J Rheumatol. 2016;43(2):273\u201381.","journal-title":"J Rheumatol"},{"issue":"1-2","key":"1455_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","volume":"61","author":"A Yee","year":"2015","unstructured":"Yee A, Webb T, Seaman A, Infantino M, Meacci F, Manfredi M, Benucci M, Lakos G, Favalli E, Schioppo T, et al. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res. 2015;61(1-2):24\u201330.","journal-title":"Immunol Res"},{"issue":"4","key":"1455_CR11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","volume":"65","author":"J Shi","year":"2013","unstructured":"Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2013;65(4):911\u20135.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1455_CR12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","volume":"42","author":"RW Gan","year":"2015","unstructured":"Gan RW, Trouw LA, Shi J, Toes RE, Huizinga TW, Demoruelle MK, Kolfenbach JR, Zerbe GO, Deane KD, Edison JD, et al. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. J Rheumatol. 2015;42(4):572\u20139.","journal-title":"J Rheumatol"},{"key":"1455_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2017.02.008","volume":"80","author":"MK Verheul","year":"2017","unstructured":"Verheul MK, Yee A, Seaman A, Janssen GM, van Veelen PA, Drijfhout JW, Toes REM, Mahler M, Trouw LA. Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis. J Autoimmun. 2017;80:77\u201384.","journal-title":"J Autoimmun."},{"key":"1455_CR14","doi-asserted-by":"crossref","unstructured":"Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, et al. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. Rheumatology (Oxford). 2017;56(7):1217\u201326.","DOI":"10.1093\/rheumatology\/kex088"},{"issue":"8","key":"1455_CR15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/annrheumdis-2016-210772","volume":"76","author":"JS Dekkers","year":"2017","unstructured":"Dekkers JS, Verheul MK, Stoop JN, Liu B, Ioan-Facsinay A, van Veelen PA, de Ru AH, Janssen GMC, Hegen M, Rapecki S, et al. Breach of autoreactive B cell tolerance by post-translationally modified proteins. Ann Rheum Dis. 2017;76(8):1449\u201357.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1455_CR16","doi-asserted-by":"crossref","first-page":"e102163","DOI":"10.1371\/journal.pone.0102163","volume":"9","author":"JN Stoop","year":"2014","unstructured":"Stoop JN, Liu BS, Shi J, Jansen DT, Hegen M, Huizinga TW, Trouw LA, Toes RE. Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis. PLoS One. 2014;9(7):e102163.","journal-title":"PLoS One"},{"issue":"11","key":"1455_CR17","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/art.27644","volume":"62","author":"S Turunen","year":"2010","unstructured":"Turunen S, Koivula MK, Risteli L, Risteli J. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. Arthritis Rheum. 2010;62(11):3345\u201352.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1455_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.158.2.529","volume":"158","author":"DA Nemazee","year":"1983","unstructured":"Nemazee DA, Sato VL. Induction of rheumatoid antibodies in the mouse. Regulated production of autoantibody in the secondary humoral response. J Exp Med. 1983;158(2):529\u201345.","journal-title":"J Exp Med"},{"issue":"5","key":"1455_CR19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/annrheumdis-2014-206797","volume":"74","author":"JN Stoop","year":"2015","unstructured":"Stoop JN, Fischer A, Hayer S, Hegen M, Huizinga TW, Steiner G, Trouw LA, Toes RE. Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system. Ann Rheum Dis. 2015;74(5):949\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1455_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02274777","volume":"10","author":"NP Bakker","year":"1990","unstructured":"Bakker NP, van Erck MG, Zurcher C, Faaber P, Lemmens A, Hazenberg M, Bontrop RE, Jonker M. Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis? Rheumatol Int. 1990;10(1):21\u20139.","journal-title":"Rheumatol Int"},{"issue":"4","key":"1455_CR21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.175.4.933","volume":"175","author":"NP Bakker","year":"1992","unstructured":"Bakker NP, van Erck MG, Otting N, Lardy NM, Noort RC, Hart BA, Jonker M, Bontrop RE. Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region. J Exp Med. 1992;175(4):933\u20137.","journal-title":"J Exp Med"},{"key":"1455_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-015-0651-0","volume":"17","author":"M Roy Van","year":"2015","unstructured":"Van Roy M, Ververken C, Beirnaert E, Hoefman S, Kolkman J, Vierboom M, Breedveld E, Hart B, Poelmans S, Bontinck L, et al. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody(R) ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Res Ther. 2015;17:135.","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"1455_CR23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12739","volume":"183","author":"MP Vierboom","year":"2016","unstructured":"Vierboom MP, Breedveld E, Kap YS, Mary C, Poirier N, Hart BA, Vanhove B. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183(3):405\u201318.","journal-title":"Clin Exp Immunol"},{"key":"1455_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ddmod.2008.06.003","volume":"5","author":"MPM Vierboom","year":"2008","unstructured":"Vierboom MPM, Breedveld E, Hart BA. Preclinical evaluation of anti-rheumatic drugs in a non-human primate model of arthritic disease. Drug Discov Today Dis Model. 2008;5:89\u201395.","journal-title":"Drug Discov Today Dis Model."},{"issue":"10","key":"1455_CR25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40265-013-0080-9","volume":"73","author":"GM Keating","year":"2013","unstructured":"Keating GM. Abatacept: a review of its use in the management of rheumatoid arthritis. Drugs. 2013;73(10):1095\u2013119.","journal-title":"Drugs"},{"issue":"5","key":"1455_CR26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2165\/00003495-200969050-00007","volume":"69","author":"V Oldfield","year":"2009","unstructured":"Oldfield V, Dhillon S, Plosker GL. Tocilizumab: a review of its use in the management of rheumatoid arthritis. Drugs. 2009;69(5):609\u201332.","journal-title":"Drugs"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T15:47:53Z","timestamp":1509637673000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1455-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]},"article-number":"246"}}